US 7244576
Modulators of angiogenesis
granted A61KA61K38/00
Quick answer
US patent 7244576 (Modulators of angiogenesis) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/00